Concepedia

Publication | Closed Access

Phase II Study of Docetaxel, Estramustine, and Low-Dose Hydrocortisone in Men With Hormone-Refractory Prostate Cancer: A Final Report of CALGB 9780

DOI

321

Citations

25

References

2001

Year

Diane Savarese, Susan Halabi, Vera Hárs, Wallace Akerley, M-E Taplin, Paul A. Godley, Arif Hussain, Eric J. Small, Nicholas J. Vogelzang
Journal of Clinical Oncology

Abstract

This therapy is efficacious and moderately well tolerated in HRPC and should be compared in a phase III trial with mitoxantrone and prednisone.

References

YearCitations

Page 1